The United States market has shown robust performance recently, climbing 1.8% in the last week and up 28% over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this thriving environment, identifying stocks that combine strong fundamentals with growth potential can uncover hidden opportunities for investors seeking to capitalize on these positive trends.
Top 10 Undiscovered Gems With Strong Fundamentals In The United States
| Name |
Debt To Equity |
Revenue Growth |
Earnings Growth |
Health Rating |
|---|---|---|---|---|
| Bank of the James Financial Group |
10.74% |
5.28% |
3.68% |
★★★★★★ |
| Tri-County Financial Group |
54.21% |
-0.70% |
-10.52% |
★★★★★★ |
| ASA Gold and Precious Metals |
NA |
12.65% |
41.20% |
★★★★★★ |
| Oakworth Capital |
51.38% |
15.89% |
14.04% |
★★★★★★ |
| Teekay |
2.14% |
10.67% |
57.58% |
★★★★★★ |
| SIFCO Industries |
12.27% |
-4.21% |
-2.87% |
★★★★★★ |
| First Northern Community Bancorp |
NA |
7.26% |
11.00% |
★★★★★★ |
| Anbio Biotechnology |
NA |
-30.09% |
-3.45% |
★★★★★★ |
| Union Bankshares |
406.25% |
1.42% |
-7.24% |
★★★★☆☆ |
| High Templar Tech |
13.55% |
-66.76% |
-26.62% |
★★★★☆☆ |
Let's explore several standout options from the results in the screener.
Greene County Bancorp
Simply Wall St Value Rating:★★★★★★
Overview:Greene County Bancorp, Inc. operates as a holding company for The Bank of Greene County, offering a range of financial services in the United States with a market cap of $429.89 million.
Operations:The company generates revenue primarily from its banking operations, amounting to $87.05 million.
Greene County Bancorp, with total assets of US$3.2 billion and equity of US$267.6 million, showcases robust financial health. Total deposits stand at US$2.8 billion against loans of US$1.7 billion, supported by a sufficient allowance for bad loans at 709%. The bank's earnings growth over the past year was an impressive 36.7%, outpacing the industry average of 22.8%. It operates with primarily low-risk funding sources, as customer deposits make up 95% of liabilities. Recent announcements include a share repurchase program for up to 400,000 shares and a steady quarterly dividend payout of $0.10 per share.
Viemed Healthcare
Simply Wall St Value Rating:★★★★★★
Overview:Viemed Healthcare, Inc. operates in the United States, offering home medical equipment and post-acute respiratory healthcare services, with a market capitalization of approximately $379.15 million.
Operations:Viemed Healthcare generates revenue primarily from healthcare facilities and services, totaling $286.57 million. The company focuses on providing home medical equipment and post-acute respiratory healthcare services in the United States.
Viemed Healthcare, a nimble player in the healthcare sector, has shown robust financial health with its interest payments well covered by EBIT at 19.1 times. Trading significantly below its estimated fair value by 64.2%, it offers potential upside for investors. The company's debt to equity ratio has improved from 9% to 6.3% over five years, while earnings grew impressively by 21.2% last year, outpacing the industry average of 17%. Despite recent insider selling and net income holding steady at US$2.58 million this quarter compared to US$2.63 million a year ago, Viemed's strategic share repurchase of $1.39 million signals confidence in its prospects amidst plans for acquisitions and organic growth initiatives.
-
Click to explore a detailed breakdown of our findings in Viemed Healthcare's health report.
-
Assess Viemed Healthcare's past performance with our detailed historical performance reports.
Ennis
Simply Wall St Value Rating:★★★★★★
Overview:Ennis, Inc. is a company that produces and sells business forms and other printed products in the United States with a market cap of approximately $518.76 million.
Operations:The company generates revenue primarily from its print segment, which reported $392.40 million. The gross profit margin is 29.5%, indicating the efficiency of its production processes in relation to costs.
With a market presence that reflects steady growth, Ennis has experienced an 8.5% annual increase in earnings over the past five years, underscoring its high-quality earnings and debt-free status. Trading at 41.6% below estimated fair value, this company seems undervalued given its robust financial health. Recent reports show sales of US$96 million for the fourth quarter of 2026, slightly up from US$92 million the previous year, while net income saw a modest dip to US$8.85 million from US$9.02 million last year. The company also declared a quarterly dividend of $0.25 per share in March 2026, reinforcing shareholder returns amidst stable performance metrics like basic EPS holding steady at $0.35 compared to last year's figure.
-
Unlock comprehensive insights into our analysis of Ennis stock in this health report.
-
Examine Ennis' past performance report to understand how it has performed in the past.
Seize The Opportunity
-
Dive into all 337 of the US Undiscovered Gems With Strong Fundamentals we have identified here.
-
Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
-
Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Ready To Venture Into Other Investment Styles?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
-
Find companies with promising cash flow potential yet trading below their fair value .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include GCBC VMD and EBF .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
